Stock Events

Stock Events

Johnson & Johnson 

$275.23
43951
-$3.20-1.15% 20:00 Today
+$0.27+0.1%21:52After hours

Statistics

Day High
277.8
Day Low
274.75
52W High
281.07
52W Low
173.33
Volume
3,878,977
Avg. Volume
7,850,414
Mkt Cap
663.28B
P/E Ratio
29.78
Dividend Yield
1.95%
Dividend
5.36

Upcoming

Dividends

1.95%Dividend Yield
Sep 26
$1.34
Jun 26
$1.34
Mar 26
$1.30
Dec 25
$1.30
Sep 25
$1.30
10Y Growth
5.56%
5Y Growth
5.08%
3Y Growth
4.59%
1Y Growth
4.38%

Earnings

13OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
2.46
2.61
2.75
2.9
Expected EPS
2.899014
Actual EPS
N/A

Financials

28.46%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
94.19BRevenue
26.8BNet Income

Analyst Ratings

280.46Average Price Target
The highest estimate is 320.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
77%
Hold
23%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ. It's not an investment recommendation.
Coca-Cola
12725
KO
Realty Income
11550
O
Apple
11307
AAPL
Microsoft
11142
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap366B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap292.35B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Show more...
CEO
Joaquin Duato
Employees
140800
Country
United States
ISIN
US4781601046
WKN
000853260

Listings

MU
DE
JNJ.MU
F
DE
JNJ0.F
BA
AR
JNJ.BA
BK
TH
JNJ03.BK

0 Comments

Share your thoughts

FAQ

What is Johnson & Johnson stock price today?▼
The current price of JNJ is $275.23 USD — it has decreased by -1.15% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
What is Johnson & Johnson stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Johnson & Johnson stocks are traded under the ticker JNJ.
Is Johnson & Johnson stock price growing?▼
JNJ stock has risen by +2.68% compared to the previous week, the month change is a +7.96% rise, over the last year Johnson & Johnson has showed a +53.97% increase.
What is Johnson & Johnson market cap?▼
Today Johnson & Johnson has the market capitalization of 663.28B
When is the next Johnson & Johnson earnings date?▼
Johnson & Johnson is going to release the next earnings report on October 13, 2026.
What were Johnson & Johnson earnings last quarter?▼
JNJ earnings for the last quarter are 2.9 USD per share, whereas the estimation was 2.85 USD resulting in a +1.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Johnson & Johnson revenue for the last year?▼
Johnson & Johnson revenue for the last year amounts to 94.19B USD.
What is Johnson & Johnson net income for the last year?▼
JNJ net income for the last year is 26.8B USD.
Does Johnson & Johnson pay dividends?▼
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.34 USD. As of today, Dividend Yield (FWD)% is 1.95%.
How many employees does Johnson & Johnson have?▼
As of September 04, 2026, the company has 140,800 employees.
In which sector is Johnson & Johnson located?▼
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?▼
The last stock split for Johnson & Johnson was on June 13, 2001 with a ratio of 2:1.
Where is Johnson & Johnson headquartered?▼
Johnson & Johnson is headquartered in NEW BRUNSWICK, United States.